With innovation at its core, Genex is a global leader in the development of enabling products, scientific knowledge, and technical expertise within a wide range of applications.

At Genex, innovative product development is vital to our sustained growth and as a result, we are improving both the speed to market of our products and the value of our product introductions to customers.

Inspired by a newly-formed Breakthrough Innovation Group, Genex is actively exploring opportunities that stretch business and technology boundaries. As we work to more formally systemize our approach to innovation, however, we clearly realize that understanding customer needs is what distinguishes us from other technology organizations.

 

 



World Class Dedicated manufacturing facilities for formulations as well as APIs further exemplify our expertise in manufacturing variety of dosage forms. All manufacturing sites are WHO-GMP approved and new state-of-the-art manufacturing facilities are applied for registration at USFDA, UKMHRA and TGA-Australia. .

Our state-of-the-art manufacturing facilities have following salient features:

  • Fully computerized Heating,Ventilating and Air-conditioning System (HVAC).
  • Production area made of sandwich panels & self-leveling PVC flooring.
  • Validation Master Plan (VMP) as per European GMP 2002 and CGMP 210 & 211.
  • Modern QA, QC, Microbiological and PD Lab supported with high-tech equipments.
  • Fully automated with electronically controlled operating system as per GAMP-4 (Good Automated Manufacturing Practice) guidelines.
  • Sophisticated Effluent Treatment Plant (ETP) with the capacity of 100000 Ltrs/day making it environment friendly company.
  • Built to conform international environmental, health & safety regulations.



I. FORMULATION

1. Oncology Unit dedicated to manufacturing of our leading anti-cancer formulations

  • Lyophilization
  • Sterile - Liquid Ampoule / Vial, Dry Powder
  • Tablets & Capsules
2. Hormones Unit dedicated to manufacturing the highly purified hormonal preparations such as Gonadotrophins
  • Lyophilization
  • Sterile - Liquid Ampoule / Vial
  • Tablets & Capsules
3. General Formulation Unit, dedicated to manufacturing of various dosage forms including other critical care and cardiovascular formulations
  • Lyophilization
  • Sterile - Liquid Ampoule / Vial, Dry Powder
  • Sterile Ophthalmic Formulations
  • Tablets, Capsules And Syrup
  • Soft Gelatin Capsules
  • Aerosols
  • Cream & Ointments

4. Cepahalosporin Unit , further divided into 2 separate facilities :

  • Cepahalosporin facility specialized in manufacturing of lifesaving cephalosporin formulations for

    • - Injectables
    - Tablets & Capsules
  • Beta Lactam facility, specialized in manufacturing of lifesaving antibiotics as

    • - Oral Solids
    - Injectables

II. ACTIVE PHARMACEUTICAL INGREDIENTS (API's)

Stringent Process Norms

Genex believes in the philosophy of Brand Building and this belief results in its deep commitment to product quality. At Genex quality is not by mere chance, but is the result of systematic and intelligent work.

The pedestal on which product quality at Genex Pharma benchmarks itself, is stringent adherence & follow up of standard protocol involving approved procedures, production planning and control process with complete documentation.

All procedures of Quality Control follow stringent in-process checks at every stage leaving nothing to chance. Documentation is carried out for every process resulting in more than adequate record of each and every data generated.

In compliance with cGMP norms, the entire manufacturing is spearheaded keeping close eye on national & international regulatory norms and more importantly our client's customary requirements.